Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:50:02 EDT Wed 23 Apr 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
Q:IPHA
- INNATE PHARMA SPON ADS EACH REP 1 ORD SHS -
Website unknown - click to update
20:50:02 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
IPHA
- Q
2.5
1.79
·
2.39
2.0
1.9955
+0.07
3.6
61.2
109
175
2.10
2.19
1.96
3.5107 1.29
16:00:03
01:00
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 175
More trades...
Time ET
Ex
Price
Change
Volume
16:00:03
Q
1.97
0.01
4
15:59:35
Q
1.98
0.02
91
15:59:30
Q
1.99
0.03
4
15:59:17
Q
1.99
0.03
2
15:58:37
Q
1.99
0.03
3
15:58:15
Q
1.99
0.03
50
15:57:37
Q
1.97
0.01
3
15:57:25
Q
1.99
0.03
30
15:57:25
Q
1.99
0.03
31
15:56:16
Q
1.965
0.005
3
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-04-23 01:00
U:IPHA
News Release
200
Innate Pharma Regains Its Rights on CD123 Targeting ANKET(TM) and Announces Sanofi's Intention to Make a Strategic Investment in the Company
2025-04-16 01:00
U:IPHA
News Release
200
Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition
2025-04-16 01:00
U:IPHA
News Release
200
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025
2025-04-03 01:00
U:IPHA
News Release
200
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
2025-03-27 02:00
U:IPHA
News Release
200
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
2025-03-26 02:00
U:IPHA
News Release
200
Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting
2025-03-20 02:00
U:IPHA
News Release
200
Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results
2025-02-27 01:00
U:IPHA
News Release
200
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
2025-02-17 01:02
U:IPHA
News Release
200
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sezary Syndrome
2025-01-27 01:00
U:IPHA
News Release
200
Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors
2025-01-21 01:00
U:IPHA
News Release
200
Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York
2025-01-16 01:00
U:IPHA
News Release
200
Number of Shares and Voting Rights of Innate Pharma as of December 31, 2024
2025-01-10 01:00
U:IPHA
News Release
200
Innate Pharma Announces Transformative Strategy to Accelerate Growth
2024-12-20 01:00
U:IPHA
News Release
200
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-09 01:00
U:IPHA
News Release
200
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
2024-12-06 01:00
U:IPHA
News Release
200
Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma
2024-12-03 01:00
U:IPHA
News Release
200
Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
2024-11-20 01:00
U:IPHA
News Release
200
Innate Pharma Releases Its 2025 Financial Calendar
2024-11-19 01:00
U:IPHA
News Release
200
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET(TM) IPH6501
2024-11-13 01:00
U:IPHA
News Release
200
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results